| MLR | mean length response; middle latency response; mixed lymphocyte reaction |
|---|---|
| PR | by way of the rectum [Lat. per rectum]; far point [of accommodation] [Lat. punctum remotum]; palindr... |
| RVR | reduced vascular response; renal vascular resistance; repetitive ventricular response; resistance to... |
| SER | sebum excretion rate; sensitizer enhancement ratio; sensory evoked response; service; smooth endopla... |
| SIRS | soluble immune response suppressor; Structured Interview of Reported Symptoms; systemic inflammatory... |
| fasciitis, plantar | Inflammation of the plantar fascia (fasciitis), the bowstring-like tissue stretching underneath the sole which attaches at the heel. (12 Dec 1998) |
|---|---|
| lateral plantar artery | <anatomy, artery> Larger of the two terminal branches of the posterior tibial; distribution, forms the plantar arch and through it supplies the sole of the foot and plantar surfaces of the toes; anastomoses, medial plantar, dorsalis pedis. Synonym: arteria plantaris lateralis. (05 Mar 2000) |
| lateral plantar nerve | <anatomy, nerve> One of the two terminal branches of the tibial nerve; it courses along the lateral side of the sole, dividing into superficial and deep branches; it supplies the skin of the lateral aspect of the sole and the lateral one and one-half toes; it innervates the intrinsic muscles of the plantar part of the foot with the exception of the abductor hallucis and the flexor digitorum brevis; its distribution in the foot is very similar to that of the ulnar nerve in the hand. Synonym: nervus plantaris lateralis. (05 Mar 2000) |
| long plantar ligament | <anatomy> A strong ligament that extends from the calcaneus to the cuboid and lateral metatarsals on the plantar aspect of the foot; part of the passive support system for maintaining the longitudinal arch of the foot. Synonym: ligamentum plantare longum. (05 Mar 2000) |
| anamnestic response | <immunology> Archaic term now replaced by such terms as secondary immune response, immune memory. (18 Nov 1997) |
| audiometry, evoked response | A form of electrophysiologic audiometry in which an analog computer is included in the circuit to average out ongoing or spontaneous brain wave activity. A characteristic pattern of response to a sound stimulus may then become evident. Evoked response audiometry is known also as electric response audiometry. (12 Dec 1998) |
| auditory brainstem response audiometry | An electrophysiologic measure of auditory function utilizing responses produced by the auditory nerve and the brainstem to repetitive acoustic stimuli. (05 Mar 2000) |
| biological response modifier | <pharmacology, oncology> A substance used in adjuvant therapy that takes advantage of the bodys own natural defense mechanisms to inhibit the growth of a tumour. (16 Dec 1997) |
| biological response modifiers | Substances that stimulate the body's response to infection and disease. The body naturally produces small amounts of these substances. Scientists can produce some of them in the laboratory in large amounts and use them in cancer treatment. Also called BRMs. (12 Dec 1998) |
| biphasic response | Two separate and distinct responses that are separated in time, immediate reaction to an antigenic challenge followed by a recurrence of symptoms after an interval of quiescence. (05 Mar 2000) |
| booster response | The response of the immune system to the second or subsequent occasion on which it encounters a specific antigen. (18 Nov 1997) |
| brainstem evoked response audiometry | An electrophysiologic measure of auditory function utilizing responses produced by the auditory nerve and the brainstem to repetitive acoustic stimuli. (05 Mar 2000) |
| galvanic skin response | A change in electrical resistance of the skin, occurring in emotion and in certain other conditions. (12 Dec 1998) |
| recruiting response | <neurology> The gradual increase to a maximum in a reflex when a stimulus of unaltered intensity is prolonged. (12 Dec 1998) |
| partial response | <oncology> A decrease of at least 50 percent in the sum of the measurements of all evaluable target lesions or tumours seen in a study. (16 Dec 1997) |